TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21399471

Group type: EXPERIMENTAL
Intervention: External fixation for stable intertrochanteric fractures (Group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: External fixation for unstable intertrochanteric fractures (Group B)
Number of subjects: 100
Study: 18200431

Group type: EXPERIMENTAL
Intervention: OCD with ADHD
Number of subjects: 40

Group type: COMPARATOR
Intervention: OCD without ADHD
Number of subjects: 40
Study: 16443598

Group type: EXPERIMENTAL
Intervention: Psychopathy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control (heterosexual male confederate)
Number of subjects: 84
Study: 15120552

Group type: EXPERIMENTAL
Intervention: Cross-modal (auditory-visual) priming with regular verbs (with and without orthographically salient morphemic aspectual markers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cross-modal (auditory-visual) priming with irregular verbs
Number of subjects: 0
Study: 11181383

Group type: EXPERIMENTAL
Intervention: 3-day quinine-clindamycin regimen (group QC)
Number of subjects: 108

Group type: COMPARATOR
Intervention: 7-day quinine regimen (group Q)
Number of subjects: 108
Study: 9074306

Group type: EXPERIMENTAL
Intervention: Moclobemide (mean dose 440 mg +/- 123 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Fluoxetine (mean dose 35 mg +/- 8 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Fluoxetine (Control)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Moclobemide (Intervention)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 150
Study: 8379625

Group type: EXPERIMENTAL
Intervention: Routine on-table cholangiography (R)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Selective on-table cholangiography (S)
Number of subjects: 167
Study: 3021407

Group type: EXPERIMENTAL
Intervention: High-carbohydrate, guar gum fiber (HCF) bars (35.7 g carbohydrate and 6.6 g guar gum/bar)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo bars (identical except for the absence of guar gum)
Number of subjects: 16
Study: 29119799

Group type: EXPERIMENTAL
Intervention: Faith-based anti-stigma intervention
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 199
Study: 27496046

Group type: EXPERIMENTAL
Intervention: Norwegian Psychomotor Physiotherapy (NPMP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive Patient Education in combination with active individualized physiotherapy (COPE-PT)
Number of subjects: 0
Study: 23716067

Group type: EXPERIMENTAL
Intervention: MTX plus hydroxychloroquine plus sulfasalazine plus low-dose prednisone (arm 1)
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: MTX plus adalimumab (ADA) (arm 2)
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Initial treatment with MTX and prednisone
Number of subjects: 610

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 610
Study: 22706949

Group type: EXPERIMENTAL
Intervention: Intermittent exercise at 105% ICS (IE(105))
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intermittent exercise at 110% ICS (IE(110))
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intermittent exercise at 125% ICS decreased to 105% ICS (IE(125‐105))
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intermittent exercise at 125% ICS decreased to 110% ICS (IE(125‐110))
Number of subjects: 7
Study: 19926503

Group type: EXPERIMENTAL
Intervention: Autologous blood injection into the superior joint space (SJS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Autologous blood injections to the SJS and the pericapsular tissues (PT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 30
Study: 18539084

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (constant medication)
Number of subjects: 20
Study: 15316710

Group type: EXPERIMENTAL
Intervention: 5 mg diazepam
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 10 mg diazepam
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 12712782

Group type: EXPERIMENTAL
Intervention: Alfentanil infusion
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Propofol total intravenous anaesthesia
Number of subjects: 25
Study: 10993127

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (50-100 mg/day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 8959316

Group type: EXPERIMENTAL
Intervention: Regular NSAID use (at least twice weekly for 12 months or longer)
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Nonaspirin NSAID use
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Aspirin use
Number of subjects: 477

Group type: COMPARATOR
Intervention: Control group (non-NSAID users)
Number of subjects: 477
Study: 1388048

Group type: EXPERIMENTAL
Intervention: Fadrozole 1 mg orally per day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fadrozole 4 mg orally per day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fadrozole (1 or 4 mg)
Number of subjects: 80
Study: 3933029

Group type: EXPERIMENTAL
Intervention: + oxaprotiline
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: desipramine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: - oxaprotiline
Number of subjects: 6

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6
Study: 29028463

Group type: EXPERIMENTAL
Intervention: Stanford ADHD protocol
Number of subjects: 35

Group type: COMPARATOR
Intervention: Pre-protocol assessment
Number of subjects: 35
Study: 27322481

Group type: EXPERIMENTAL
Intervention: AERAS-422 high dose (>10(6)‐<10(7)CFU)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: AERAS-422 low dose (>10(5)‐<10(6)CFU)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Tice BCG (1‐8×10(5)CFU)
Number of subjects: 24
Study: 24296957

Group type: EXPERIMENTAL
Intervention: PQ‐alexidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PQ‐MAPDA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: balafilcon A
Number of subjects: 0
Study: 22834768

Group type: EXPERIMENTAL
Intervention: 8 weeks treatment with vaginal progesterone
Number of subjects: 0

Group type: COMPARATOR
Intervention: 8 weeks placebo
Number of subjects: 0
Study: 20727543

Group type: EXPERIMENTAL
Intervention: Back fill technique
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Auto fill technique
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Overall patient outcomes
Number of subjects: 79
Study: 18728521

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 15238430

Group type: EXPERIMENTAL
Intervention: Self-triggered tones (subjects pressed a button every 5 s)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Externally triggered tones (passively listened)
Number of subjects: 12
Study: 12118018

Group type: EXPERIMENTAL
Intervention: Concurrent thoracic radiotherapy (TRT)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Sequential thoracic radiotherapy (TRT)
Number of subjects: 231
Study: 9703402

Group type: EXPERIMENTAL
Intervention: Skeletal traction
Number of subjects: 78

Group type: COMPARATOR
Intervention: Skin traction
Number of subjects: 78
Study: 7851354

Group type: EXPERIMENTAL
Intervention: Intrathecal infusion with a bolus dose of 100 micrograms morphine followed by a 24 h infusion of 200 micrograms morphine (8.3 micrograms h‐1)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Epidural infusion with a bolus dose of 2 mg of morphine followed by a 24 h infusion of morphine 200 micrograms h‐1 + 0.25% bupivacaine 4 ml h‐1
Number of subjects: 55
Study: 2895963

Group type: EXPERIMENTAL
Intervention: HOE 760 (histamine H2-receptor antagonist)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29045949

Group type: EXPERIMENTAL
Intervention: Active Video Game Group (AVGG)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 39
Study: 26798023

Group type: EXPERIMENTAL
Intervention: Tapentadol Extended Release (ER)
Number of subjects: 2276
Study: 25418493

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/d
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ezetimibe 20 mg/d
Number of subjects: 22
Study: 24184815

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (MgSO4) 16 mmol IV followed by 5 mmol over two hours
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 21645424

Group type: EXPERIMENTAL
Intervention: Self‐administered, semiquantitative food frequency questionnaire (FFQ)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Three days of nonconsecutive three‐day food records (3D‐FRs)
Number of subjects: 107
Study: 19114887

Group type: EXPERIMENTAL
Intervention: 4% albumin (Alb: n = 59)
Number of subjects: 119

Group type: COMPARATOR
Intervention: 6% hydroxyethyl starch 130/0.4 (HES: n = 60)
Number of subjects: 119
Study: 16774480

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CsA) - 24-hour intravenous infusion
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 15322436

Group type: EXPERIMENTAL
Intervention: CEI of 0.5% bupivacaine plus IEB of 0.5% bupivacaine 4 times daily (n = 29)
Number of subjects: 56

Group type: COMPARATOR
Intervention: IEB of normal saline plus IEB of 0.5% bupivacaine 4 times daily (n = 27)
Number of subjects: 56
Study: 11771598

Group type: EXPERIMENTAL
Intervention: Target Controlled Infusion (TCI) of propofol (3 to 8 microg/ml)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manually Controlled Infusion (MCI) of propofol (approximately 2 mg/kg bolus and 3 to 10 mg/kg/h infusion)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Target Controlled Infusion (TCI) of propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manually Controlled Infusion (MCI) of propofol
Number of subjects: 40
Study: 9402499

Group type: EXPERIMENTAL
Intervention: Propolis-containing mouthrinse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthrinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive control
Number of subjects: 0
Study: 8499957

Group type: EXPERIMENTAL
Intervention: Continuous oral conjugated equine estrogens, 0.625 mg daily, with sequential oral dl‐norgestrel, 0.15 mg daily, for 12 days per month
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Continuous transdermal estradiol‐17 beta, 0.05 mg daily, with sequential transdermal norethindrone acetate, 0.25 mg daily, for 14 days per month
Number of subjects: 96

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 96
Study: 6697024

Group type: EXPERIMENTAL
Intervention: In vivo exposure (2 sessions)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Imaginal exposure (2 sessions)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Imaginal followed by in vivo exposure (2 sessions)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: In vivo followed by imaginal exposure (2 sessions)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Hypothesized cues
Number of subjects: 64
Study: 31780009

Group type: EXPERIMENTAL
Intervention: Guided yoga
Number of subjects: 18

Group type: COMPARATOR
Intervention: Light stretching protocol
Number of subjects: 18
Study: 28803345

Group type: EXPERIMENTAL
Intervention: Cervical anterior discectomy procedure for cervical single level degenerative disc disease
Number of subjects: 0
Study: 27018174

Group type: EXPERIMENTAL
Intervention: CPAP + ME
Number of subjects: 83

Group type: COMPARATOR
Intervention: CPAP only
Number of subjects: 83
Study: 25257871

Group type: EXPERIMENTAL
Intervention: Inhalation of 15 mg of terbutaline (TER)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 9
Study: 22486552

Group type: EXPERIMENTAL
Intervention: Pantoprazole treatment for up to 16 weeks
Number of subjects: 626

Group type: COMPARATOR
Intervention: Observational phase after pantoprazole treatment
Number of subjects: 626
Study: 20828102

Group type: EXPERIMENTAL
Intervention: Four session brief motivational intervention encouraging organ donation
Number of subjects: 2789

Group type: COMPARATOR
Intervention: Four session stylist-delivered health education program (comparison)
Number of subjects: 2789
Study: 17094978

Group type: EXPERIMENTAL
Intervention: Mifepristone (25 mg, two pills every 14 days during DMPA therapy)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (two pills every 14 days during DMPA therapy)
Number of subjects: 50
Study: 17848882

Group type: EXPERIMENTAL
Intervention: 0.25 mL Epaxal
Number of subjects: 308

Group type: COMPARATOR
Intervention: 0.5 mL Epaxal
Number of subjects: 308

Group type: COMPARATOR
Intervention: Havrix Junior
Number of subjects: 308

Group type: COMPARATOR
Intervention: Local injection site pain
Number of subjects: 308
Study: 15024364

Group type: EXPERIMENTAL
Intervention: NaOCl irrigation with cold lateral condensation (CLC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NaOCl irrigation with warm vertical condensation (WVC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NaOCl+EDTA irrigation with cold lateral condensation (CLC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NaOCl+EDTA irrigation with warm vertical condensation (WVC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 40
Study: 11232181

Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic shunts (TIPS)
Number of subjects: 0
Study: 9010709

Group type: EXPERIMENTAL
Intervention: Sauna bathing session (temperature 85-100 degrees C, relative humidity 25-30%)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control session
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intravenous midazolam (0.05 mg.kg-1)
Number of subjects: 6
Study: 1596551

Group type: EXPERIMENTAL
Intervention: Gd-BOPTA (0.05-0.1 mmol/kg body weight)
Number of subjects: 8
Study: 6529913

Group type: EXPERIMENTAL
Intervention: Trazodone (223 mg daily)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Amitriptyline (95.3 mg daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31409112

Group type: EXPERIMENTAL
Intervention: Clinical trial evidence of a 'medication'
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Clinical trial evidence of a 'topical steroid'
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Anecdote of a 'medication'
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Anecdote of a 'topical steroid'
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Both clinical trial evidence and anecdote of a 'medication'
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Both clinical trial evidence and anecdote of a 'topical steroid'
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Doctor's recommendation
Number of subjects: 476

Group type: COMPARATOR
Intervention: No safety information provided
Number of subjects: 476
Study: 31067223

Group type: EXPERIMENTAL
Intervention: 18-week supervised moderate-to-high intensity aerobic and resistance exercise program (two 1-hour sessions/week)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: High-intensity aerobic exercise (cycling at the ventilatory threshold)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Muscle strength exercises
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Exercise advice
Number of subjects: 92
Study: 28971804

Group type: EXPERIMENTAL
Intervention: Truview PCD
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: C-MAC
Number of subjects: 150

Group type: COMPARATOR
Intervention: Macintosh
Number of subjects: 150
Study: 25353684

Group type: EXPERIMENTAL
Intervention: MD + EVOO (n = 41)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: MD + Nuts (n = 27)
Number of subjects: 98

Group type: COMPARATOR
Intervention: LFD (n = 30)
Number of subjects: 98
Study: 23768224

Group type: EXPERIMENTAL
Intervention: Gain-framed messages
Number of subjects: 64

Group type: COMPARATOR
Intervention: Loss-framed messages
Number of subjects: 64
Study: 21939467

Group type: EXPERIMENTAL
Intervention: DBS + Optimal Drug Therapy (ODT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Optimal Drug Therapy (ODT)
Number of subjects: 30
Study: 19491396

Group type: EXPERIMENTAL
Intervention: Auditory cues
Number of subjects: 133

Group type: COMPARATOR
Intervention: Visual cues
Number of subjects: 133

Group type: COMPARATOR
Intervention: Somatosensory cues
Number of subjects: 133

Group type: COMPARATOR
Intervention: No cues
Number of subjects: 133
Study: 16931693

Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES) technique
Number of subjects: 218

Group type: COMPARATOR
Intervention: Mechanical Paresthesia (MP) technique
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 218
Study: 14622048

Group type: EXPERIMENTAL
Intervention: Template Theory (TT)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Constraint Attunement Hypothesis (CAH)
Number of subjects: 36
Study: 11113398

Group type: EXPERIMENTAL
Intervention: Exercise (3 sessions/week for 2 years)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Non-exercise (control group)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Oral contraceptive use
Number of subjects: 123
Study: 9036412

Group type: EXPERIMENTAL
Intervention: Chemotherapy treatment according to the protocol of the German AML‐Cooperative Group (Münster, FRG)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Inpatient treatment
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Antileukemic therapy
Number of subjects: 61
Study: 1545464

Group type: EXPERIMENTAL
Intervention: Telephone care (clinician-initiated telephone calls, double the recommended interval for face-to-face follow-up, three intervening telephone contacts)
Number of subjects: 497

Group type: COMPARATOR
Intervention: Usual care (control group, unchanged follow-up interval)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Telephone care for subgroup of patients with fair or poor overall health (n = 180)
Number of subjects: 497
Study: 4043711

Group type: EXPERIMENTAL
Intervention: 9-deoxy-16, 16-dimethyl-9-methylene prostaglandin E2 (vaginal suppository)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 30802185

Group type: EXPERIMENTAL
Intervention: Disease management program intervention group (n=156)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Usual care group (n=165)
Number of subjects: 321
Study: 29924040

Group type: EXPERIMENTAL
Intervention: Posterior paraspinal muscle approach (PPMA)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Post-middle approach (PA)
Number of subjects: 62
Study: 27552848

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Standard AEDs (VPA-ER, CBZ-CR)
Number of subjects: 308

Group type: COMPARATOR
Intervention: VPA-ER
Number of subjects: 308

Group type: COMPARATOR
Intervention: CBZ-CR
Number of subjects: 308
Study: 24170677

Group type: EXPERIMENTAL
Intervention: Chronic anthocyanin consumption (500 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acute anthocyanin consumption (single bolus)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chronic vs Acute exposure
Number of subjects: 0
Study: 22771848

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg daily for 8 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 24
Study: 21145519

Group type: EXPERIMENTAL
Intervention: Intensive electrical stimulation (ES) for 1 hour over the quadriceps 5 days per week for 6 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Usual rehabilitative care
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Intensive electrical stimulation (ES)
Number of subjects: 26
Study: 17387192

Group type: EXPERIMENTAL
Intervention: Oral sildenafil (0.3 mg x kg(‐1), every 3 hours for 24‐48 hours)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no sildenafil)
Number of subjects: 22
Study: 16261199

Group type: EXPERIMENTAL
Intervention: Recombinant human interferon alpha‐2b for nasal spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 11345492

Group type: EXPERIMENTAL
Intervention: Close reach position
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Higher step
Number of subjects: 20

Group type: COMPARATOR
Intervention: Far reach position
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lower step
Number of subjects: 20
Study: 9724114

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 3500
Study: 8605504

Group type: EXPERIMENTAL
Intervention: Placement of dense non‐resorbable hydroxyapatite granules into fresh canine sockets at the time of immediate denture provision
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no hydroxyapatite granules)
Number of subjects: 35
Study: 2751788

Group type: EXPERIMENTAL
Intervention: Conducting a brief sexual history interview with a community volunteer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observing a brief sexual history interview
Number of subjects: 0

Group type: COMPARATOR
Intervention: No experience taking a sexual history
Number of subjects: 0
Study: 30672253

Group type: COMPARATOR
Intervention: Warm acupuncture (Jianzhen (SI 9), Jianyu (LI 15), Jianliao (TE 14), etc.)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Yoga posture method
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Warm acupuncture combined with yoga posture method
Number of subjects: 90
Study: 29117180

Group type: EXPERIMENTAL
Intervention: Residual insecticide treatment (RIT)
Number of subjects: 15750

Group type: EXPERIMENTAL
Intervention: Insecticide-treated curtains (ITC)
Number of subjects: 15750

Group type: COMPARATOR
Intervention: Routine Aedes control activities (control group)
Number of subjects: 15750
Study: 25625810

Group type: EXPERIMENTAL
Intervention: Simultaneous intervention (F/V+, Sed-, PA+)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Sequential intervention (F/V+, Sed- first, then PA+)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Stress Management Control
Number of subjects: 250
Study: 22832419

Group type: EXPERIMENTAL
Intervention: High-Power Strength Group (HPSG)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Functional Strength Group (FSG)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 63
Study: 21876043

Group type: EXPERIMENTAL
Intervention: Voriconazole plus fluconazole
Number of subjects: 10

Group type: COMPARATOR
Intervention: Voriconazole only
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Voriconazole after fluconazole
Number of subjects: 10